DK172673B1 - Immunstimulerende præparat samt anvendelse heraf - Google Patents

Immunstimulerende præparat samt anvendelse heraf Download PDF

Info

Publication number
DK172673B1
DK172673B1 DK198905403A DK540389A DK172673B1 DK 172673 B1 DK172673 B1 DK 172673B1 DK 198905403 A DK198905403 A DK 198905403A DK 540389 A DK540389 A DK 540389A DK 172673 B1 DK172673 B1 DK 172673B1
Authority
DK
Denmark
Prior art keywords
fatty acids
omega
composition according
arginine
unit dose
Prior art date
Application number
DK198905403A
Other languages
Danish (da)
English (en)
Other versions
DK540389A (da
DK540389D0 (da
Inventor
J Wesley Alexander
Vigen K Babayan
George L Blackburn
Frank B Cerra
John M Daly
Mitchell T Gersovitz
John E Kinsella
Jerome J Licari
Frederick Rudolph
Charles T Van Buren
Original Assignee
Novartis Nutrition Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Nutrition Ag filed Critical Novartis Nutrition Ag
Publication of DK540389D0 publication Critical patent/DK540389D0/da
Publication of DK540389A publication Critical patent/DK540389A/da
Application granted granted Critical
Publication of DK172673B1 publication Critical patent/DK172673B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/05—Immunological preparations stimulating the reticulo-endothelial system, e.g. against cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pediatric Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK198905403A 1988-10-31 1989-10-30 Immunstimulerende præparat samt anvendelse heraf DK172673B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US26537388A 1988-10-31 1988-10-31
US26537388 1988-10-31
US30587789A 1989-02-02 1989-02-02
US30587789 1989-02-02
US42104589A 1989-10-13 1989-10-13
US42104589 1989-10-13

Publications (3)

Publication Number Publication Date
DK540389D0 DK540389D0 (da) 1989-10-30
DK540389A DK540389A (da) 1990-05-01
DK172673B1 true DK172673B1 (da) 1999-05-10

Family

ID=27401801

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198905403A DK172673B1 (da) 1988-10-31 1989-10-30 Immunstimulerende præparat samt anvendelse heraf

Country Status (8)

Country Link
EP (1) EP0367724B1 (de)
JP (1) JP2520488B2 (de)
AU (1) AU626930B2 (de)
CA (1) CA2001727C (de)
DE (1) DE68904874T2 (de)
DK (1) DK172673B1 (de)
ES (1) ES2052066T3 (de)
HK (1) HK34694A (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5576351A (en) * 1989-12-29 1996-11-19 Mcgaw, Inc. Use of arginine as an immunostimulator
DE4304394A1 (en) * 1993-02-13 1993-09-02 Fresenius Ag Prepn. for nourishment of oncological patients - comprises fats formulation contg. oleic acid, alpha-linolenic acid, etc., and opt. carbohydrate and proteins
DE69422163T2 (de) * 1993-02-19 2000-06-15 Nippon Shinyaku Co., Ltd. Glycerolderivat, vorrichtung und pharmazeutische zusammensetzung
GB9318611D0 (en) * 1993-09-08 1993-10-27 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
WO1995009622A1 (en) * 1993-10-06 1995-04-13 Peptide Technology Limited Polyunsaturated fatty acids and uses thereof
GB9403935D0 (en) * 1994-03-01 1994-04-20 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
AUPM906594A0 (en) * 1994-10-26 1994-11-17 Peptide Technology Limited Synthetic polyunsaturated fatty acid analogues
GB9512100D0 (en) * 1995-06-14 1995-08-09 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
US5639858A (en) * 1995-03-22 1997-06-17 Tularik, Inc. Human signal transducer and binding assays
DE19528461A1 (de) * 1995-08-03 1997-02-06 Braun Melsungen Ag Präparat zur Ernährung
US6015798A (en) * 1995-10-10 2000-01-18 Colgate Palmolive Company Method for reducing the damaging effects of radiation therapy on animal skin and mucosa
US6455068B1 (en) 1995-12-26 2002-09-24 Onesta Nutrition, Inc. Dietary fiber delivery system
US6077828A (en) 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
US5891925A (en) * 1997-06-27 1999-04-06 Abbott Laboratories Diagnostic method for assessing the serum cholesterol response to low diets
EP0960572A1 (de) * 1998-05-12 1999-12-01 N.V. Nutricia Ernährungszusammensetzung zur Behandlung von Dekubitalgeschwüren
SK287423B6 (sk) * 2001-04-30 2010-09-07 Trommsdorff Gmbh & Co. Kg Arzneimittel Farmaceuticky účinné uridínové estery, ich použitie, spôsob ich prípravy a farmaceutický prostriedok
EP1665940A4 (de) 2003-09-02 2011-01-19 Bbk Bio Corp Lebensmittelpräparat
CA2539485A1 (en) * 2003-09-19 2005-03-31 N.V. Nutricia Method and composition for preventing multiple organ dysfunction syndrome
US20050215640A1 (en) 2004-03-26 2005-09-29 Baxter Jeffrey H HMB compositions and uses thereof
AU2006331950A1 (en) 2005-12-19 2007-07-05 Abbott Laboratories Use of beta-hydroxy-beta-methylbutyrate to modulate the imbalance of type 1 and type 2 cytokine production
ATE509624T1 (de) 2005-12-23 2011-06-15 Nutricia Nv Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz
ES2341163B1 (es) 2008-09-26 2011-05-11 Bioiberica, S.A. Composiciones inmunoestimulantes.
US9693577B2 (en) 2010-01-29 2017-07-04 Abbott Laboratories Method of preparing a nutritional powder comprising spray dried HMB
WO2011094548A1 (en) 2010-01-29 2011-08-04 Abbott Laboratories Aseptically packaged nutritional liquids comprising hmb
PE20121729A1 (es) 2010-01-29 2013-01-16 Abbott Lab Emulsiones nutricionales que comprenden beta-hidroxi-beta-metilbutirato (hmb) de calcio
TWI526161B (zh) 2010-06-10 2016-03-21 亞培公司 包含鈣ｈｍｂ及可溶性蛋白質之實質上透明營養液

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2471785A1 (fr) * 1979-12-21 1981-06-26 Fabre Sa Pierre Preparations immunostimulantes a base d'arn ribosomaux et procede de preparation des arn
NO862999L (no) * 1985-07-26 1987-01-27 Yeda Res & Dev Lipidblanding for membranfluidisering.
US4753963A (en) * 1985-09-26 1988-06-28 The Procter & Gamble Company Nutritional fat suitable for enteral and parenteral products

Also Published As

Publication number Publication date
JPH02191213A (ja) 1990-07-27
JP2520488B2 (ja) 1996-07-31
DK540389A (da) 1990-05-01
CA2001727C (en) 1998-02-17
EP0367724B1 (de) 1993-02-10
DK540389D0 (da) 1989-10-30
HK34694A (en) 1994-04-22
AU4386089A (en) 1990-05-03
EP0367724A1 (de) 1990-05-09
ES2052066T3 (es) 1994-07-01
DE68904874T2 (de) 1993-07-15
DE68904874D1 (de) 1993-03-25
CA2001727A1 (en) 1990-04-30
AU626930B2 (en) 1992-08-13

Similar Documents

Publication Publication Date Title
DK172673B1 (da) Immunstimulerende præparat samt anvendelse heraf
US5231085A (en) Compositions and methods for the enhancement of host defense mechanisms
AU666246B2 (en) Nutritional product for persons having a neurological injury
Barr et al. Essential fatty acid deficiency during total parenteral nutrition.
KR970005330B1 (ko) 사람 면역 결핍 바이러스에 감염된 사람에 대한 영양 제품
JP4699901B2 (ja) 体脂肪代謝機能と燃焼エネルギーの活用機能とを備えているダイエット用添加物質
SK106594A3 (en) Nutrituve supplement
JPH069384A (ja) 改良された口当たり性を有する経口的に摂取可能な栄養組成物
JP2012197293A (ja) 総合経腸栄養組成物
PL182205B1 (pl) Lek do obnizania poziomów czynnika martwicy nowotworu i preparat odzywczy PL PL PL PL
AU698846B2 (en) Method of improving the immune response
US6013273A (en) Treatment of endotoxic shock
JP4199308B2 (ja) アミノ酸組成物およびその免疫抑制における使用
EP2880993A1 (de) Verfahren zum Erreichen von Gedächtnis- und Lernverbesserung durch Verabreichung von Sialinsäure
US6864230B2 (en) Glutamine rich dietary composition
Arbeloa et al. Recommendations for specialized nutritional-metabolic management of the critical patient: Macronutrient and micronutrient requirements. Metabolism and Nutrition Working Group of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC)
Malone 15 Enteral Formulations

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired